Clinical Trials Browser

Phase 2 × NETWORK × spartalizumab × Clear all

NCT06758037 2025-03-18

HiR+X

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse

NCT03260712 2023-11-03

Pembrolizumab in Biliary Tract Cancer

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasm Metastasis